NCT00031876View on ClinicalTrials.gov

Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Breast Cancer
Interventions
DRUG

capecitabine

DRUG

paclitaxel

Trial Locations (2)

CH-3010

Inselspital, Bern, Bern

CH-8091

UniversitaetsSpital, Zurich

All Listed Sponsors
lead

Swiss Cancer Institute

OTHER

NCT00031876 - Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter